Total long-lived assets
Vertex Pharmaceuticals·Geographic·2 segments
Breakdown
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|
| Outsidethe United States | $76.3M | $90.3M | $93.2M | $192.2M | $194.6M |
| Other Countries Outsideofthe United Statesandthe United Kingdom | $15.4M | $14.6M | $15.9M | $15.6M | $27.0M |
| Total | $15.4M | $14.6M | $15.9M | $15.6M | $27.0M |
Segments
Other Countries Outsideofthe United Statesandthe United KingdomView metric
Outsidethe United StatesView metric